TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Desitin Pharma AB
Closing information (x1000 DKK)
| Closing information | 2024/09 | 2023/09 | 2022/09 |
| Turnover |
5,306
|
7,747 | |
| Financial expenses |
0
|
29 | |
| Earnings before taxes |
531
|
946 | |
| EBITDA |
531
|
975 | |
| Total assets |
5,980
|
3,980 | |
| Current assets |
5,980
|
3,980 | |
| Current liabilities |
3,120
|
833 | |
| Equity capital |
2,861
|
3,147 | |
| - share capital |
65
|
68 | |
| Employees (average) |
1
|
2
|
3 |
Financial ratios
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Solvency |
47.8%
|
79.1% | |
| Turnover per employee |
2,653
|
2,582 | |
| Profit as a percentage of turnover |
10.0%
|
12.2% | |
| Return on assets (ROA) |
8.9%
|
24.5% | |
| Current ratio |
191.7%
|
477.8% | |
| Return on equity (ROE) |
18.6%
|
30.1% | |
| Change turnover |
-2,074
|
-439 | |
| Change turnover % |
-27%
|
-28%
|
-5% |
| Chg. No. of employees |
-1
|
-1
|
0 |
| Chg. No. of employees % |
-50%
|
-33%
|
0% |
Total value of public sale
| Fiscal year | 2024/09 | 2023/09 | 2022/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.